lovastatin has been researched along with Disease Exacerbation in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (60.00) | 18.2507 |
| 2000's | 9 (30.00) | 29.6817 |
| 2010's | 3 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Justice, MJ; Kyle, SM; Vashi, N | 1 |
| Wang, J; Wu, Q; Wu, X; Zhang, LH; Zhao, YX | 1 |
| Dokmeci, MR; Ferreira, L; Khademhosseini, A; Leijten, J; Miscuglio, M; Nissan, X; Pitrez, PR; Ribas, J; Rouwkema, J; Zhang, YS | 1 |
| Girotra, S; Mittleman, MA; Mukamal, KJ; Wee, CC; Weinstein, AR | 1 |
| Bang, YJ; Jang, IJ; Kim, JR; Kim, W; Kim, YJ; Lee, HS; Yoon, JH | 1 |
| Hodis, HN; Mack, WJ; Mahrer, PR; Selzer, RH; Vigen, C | 1 |
| Girotra, S; Mittleman, MA; Mukamal, KJ | 1 |
| Bergsagel, PL; Boutros, PC; Bros, C; Clendening, JW; Jurisica, I; Khosravi, F; Martirosyan, A; Penn, LZ; Stewart, AK; Wong, WW | 1 |
| Frisinghelli, A; Mafrici, A | 1 |
| Abrahamson, D; Detrano, RC; Franklin, SS; Henein, N; Kashyap, ML; Kukes, G; Rosenzweig, B; Teng, W; Willner, R; Wong, ND | 1 |
| Berkley, V; Brouhard, BH; Cressman, M; Inman, S; Irwin, K; Satoh, S; Stowe, N; Takamori, H | 1 |
| Alaupovic, P; Blankenhorn, DH; Cashin-Hemphill, L; Corder, CN; Hodis, HN; Knight-Gibson, C; Kramsch, DM; LaBree, L; Mack, WJ | 1 |
| Bender, R | 1 |
| Craven, T; Furberg, CD; Riley, WA; Romont, A | 1 |
| Hodis, HN; Krauss, RM; Mack, WJ | 1 |
| Kroon, AA; Stalenhoef, AF; van Asten, WN | 1 |
| Benesch, L; Bestehorn, HP; Betz, P; Blümchen, G; Claus, J; Kappenberger, L; Mathes, P; Neiss, A; Rensing, UF; Roskamm, H; Schemeitat, K; Wieland, H | 1 |
| Angelin, B; Juliusson, G; Vitols, S | 1 |
| Azen, SP; Dunn, M; Hodis, HN; Mack, WJ | 1 |
| Dunn, M; Hodis, HN; Krauss, RM; Liu, C; Mack, WJ; Selzer, RH | 1 |
| Buller, C; Burton, JR; Montague, TJ; Plante, S; Teo, KK; Yokoyama, S | 1 |
| Kaysen, GA; Neverov, NI; Tareyeva, IE | 1 |
| Kozlovskaia, NL; Miroshnichenko, NG; Popova, VV; Stavrovskaia, EV; Tareeva, IE | 1 |
| Cruz, PD; Garner, LA | 1 |
| Applegate, WB; Byington, RP; Espeland, MA; Evans, GW; Furberg, CD; Hunninghake, DB; Probstfield, J | 1 |
| Cao, Z; Cooper, ME; Cox, AJ; Gilbert, RE; Jandeleit-Dahm, K; Kelly, DJ | 1 |
| Assmann, G; Breithardt, G; Eckert, S; Fleck, E; Gleichmann, U; Hanrath, P; Kerber, S; Kleemann, A; Lepper, W; Neiss, A; Schernikau, U; von Eckardstein, A | 1 |
| Granlie, C; Ijem, J | 1 |
| Griffin, BP; Lauer, MS; Novaro, GM; Pearce, GL; Sprecher, DL; Tiong, IY | 1 |
| Campeau, L; Forman, SA; Forrester, JS; Geller, NL; Gobel, FL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hunninghake, DB; Knatterud, GL; Rosenberg, Y; Terrin, ML; White, CW | 1 |
5 review(s) available for lovastatin and Disease Exacerbation
| Article | Year |
|---|---|
Rett syndrome: a neurological disorder with metabolic components.
Topics: Animals; Brain; Disease Models, Animal; Disease Progression; Drug Repositioning; Female; History, 20th Century; Humans; Lipid Metabolism; Lovastatin; Methyl-CpG-Binding Protein 2; Mice; Mutation; Quality of Life; Rett Syndrome | 2018 |
Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.
Topics: Adult; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Research Design; Risk Assessment; Risk Factors; Treatment Outcome | 2007 |
[Kidney involvement in hereditary osteo-onychodysplasia].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Lovastatin; Nail-Patella Syndrome; Nephrotic Syndrome | 1997 |
Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Gene Expression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; In Situ Hybridization; Kidney Diseases; Kidney Glomerulus; Lovastatin; Male; Nephrectomy; Pravastatin; Pyrroles; Rats; Rats, Sprague-Dawley; Simvastatin; Transforming Growth Factor beta | 1999 |
More than cholesterol: the complexity of coronary artery disease.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Disease Progression; Endothelium; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Risk Factors | 2000 |
17 trial(s) available for lovastatin and Disease Exacerbation
| Article | Year |
|---|---|
The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.
Topics: Anticoagulants; Body Mass Index; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Obesity; Postoperative Period; Prognosis; Prospective Studies; Warfarin | 2008 |
Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study).
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Disease; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models | 2005 |
Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.
Topics: Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Cholesterol, HDL; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Disease Progression; Female; Graft Occlusion, Vascular; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Prospective Studies; Risk Factors; Sensitivity and Specificity; Smoking; Warfarin | 2006 |
Noninvasive tracking of coronary atherosclerosis by electron beam computed tomography: rationale and design of the Felodipine Atherosclerosis Prevention Study (FAPS).
Topics: Aged; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Felodipine; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Research Design; Simvastatin; Tomography, X-Ray Computed | 1995 |
Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).
Topics: Adult; Aged; Apolipoproteins A; Apolipoproteins B; Cholesterol; Coronary Artery Disease; Disease Progression; Drug Monitoring; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Triglycerides | 1994 |
Assessment of temporal bias in longitudinal measurements of carotid intimal-medial thickness in the Asymptomatic Carotid Artery Progression Study (ACAPS). ACAPS Research Group.
Topics: Anticholesteremic Agents; Arteriosclerosis; Carotid Arteries; Disease Progression; Double-Blind Method; Follow-Up Studies; Humans; Lovastatin; Regression Analysis; Tunica Intima; Ultrasonography, Interventional | 1996 |
Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression.
Topics: Adult; Aged; Animals; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Humans; Lipoproteins; Lovastatin; Male; Middle Aged; Multivariate Analysis; Placebos; Regression Analysis; Remission Induction; Treatment Outcome | 1996 |
Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Enzyme Inhibitors; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Peripheral Vascular Diseases; Simvastatin | 1996 |
The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).
Topics: Adult; Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Prospective Studies; Simvastatin; Treatment Outcome | 1997 |
Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.
Topics: Adult; Aged; B-Lymphocytes; Cell Division; Cholesterol; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Leukemia, Lymphoid; Lipids; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Mitogens; Pravastatin; Simvastatin; Thymidine; Tumor Cells, Cultured | 1997 |
A comparison of quantitative computerized and human panel coronary endpoint measures: implications for the design of angiographic trials.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Computers; Coronary Angiography; Coronary Disease; Data Interpretation, Statistical; Disease Progression; Double-Blind Method; Female; Humans; Lovastatin; Male; Observer Variation; Predictive Value of Tests; Reproducibility of Results; Research Design | 1997 |
Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
Topics: Adult; Aged; Arteriosclerosis; Carotid Artery, Common; Carotid Stenosis; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, IDL; Lipoproteins, VLDL; Lovastatin; Male; Middle Aged; Risk Factors; Triglycerides; Ultrasonography | 1997 |
Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cholesterol; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Enalapril; Female; Humans; Lovastatin; Male; Middle Aged; Research Design; Simvastatin; Treatment Outcome; Ventricular Function, Left | 1997 |
Effect of lipid-lowering therapy on the progression of renal disease in nondiabetic nephrotic patients.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol; Chronic Disease; Creatinine; Diet, Fat-Restricted; Disease Progression; Female; Glomerulonephritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Lovastatin; Male; Middle Aged; Proteinuria | 1997 |
Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Topics: Adult; Aged; Arteriosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Cholesterol, LDL; Disease Progression; Double-Blind Method; Factor Analysis, Statistical; Female; Follow-Up Studies; Humans; Lovastatin; Male; Middle Aged; Sex Characteristics; Ultrasonography; Warfarin | 1999 |
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Angiography; Coronary Artery Disease; Diet; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Male; Middle Aged; Prospective Studies; Recurrence; Time Factors | 1999 |
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
Topics: Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Lipids; Lovastatin; Male; Middle Aged; Postoperative Period; Saphenous Vein; Treatment Outcome | 2001 |
8 other study(ies) available for lovastatin and Disease Exacerbation
| Article | Year |
|---|---|
The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Progression; Female; Humans; Immunohistochemistry; Lovastatin; Middle Aged; Molecular Targeted Therapy; rhoA GTP-Binding Protein; Vulvar Neoplasms | 2016 |
Biomechanical Strain Exacerbates Inflammation on a Progeria-on-a-Chip Model.
Topics: Angiotensin II; Biomechanical Phenomena; Blood Vessels; Cytoskeleton; Disease Progression; Humans; Induced Pluripotent Stem Cells; Inflammation; Lab-On-A-Chip Devices; Lovastatin; Microfluidics; Myocytes, Smooth Muscle; Phenotype; Progeria | 2017 |
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Indoles; Liver Neoplasms, Experimental; Lovastatin; Male; Mice; Mice, Inbred C3H; Microvessels; Neoplasm Transplantation; Protein Kinase C; Protein Kinase C beta | 2009 |
Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma.
Topics: Apoptosis; Disease Progression; GTP Phosphohydrolases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Multiple Myeloma | 2007 |
The combination of lovastatin and enalapril in a model of progressive renal disease.
Topics: Animals; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Lovastatin; Male; Nephrotic Syndrome; Rats; Rats, Sprague-Dawley | 1994 |
The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved.
Topics: Anticholesteremic Agents; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Humans; Lovastatin; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design | 1996 |
Contact puzzle: Worsening of a recurrent facial eruption despite treatment. Diagnosis: allergic contact dermatitis caused by desonide.
Topics: Administration, Topical; Anti-Inflammatory Agents; Anticholesteremic Agents; Desonide; Diagnosis, Differential; Disease Progression; Drug Eruptions; Drug Therapy, Combination; Facial Dermatoses; Female; Glucocorticoids; Humans; Lovastatin; Middle Aged; Patch Tests; Recurrence | 1999 |
Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.
Topics: Aged; Aortic Valve Stenosis; Atorvastatin; Calcinosis; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Echocardiography; Electrocardiography; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male; Multivariate Analysis; Pravastatin; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Treatment Outcome; Triglycerides; Vascular Patency | 2001 |